Zura Bio Limited
A clinical-stage biotechnology company focused on developing novel immunology and inflammatory drugs. The company is developing fully human monoclonal antibodies for the treatment of type 1 diabetes, chronic obstructive pulmonary disease and asthma. The company is based in the Cayman Islands.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 14 |
Founded | 2022 |
Financials | |
|---|---|
Market Capitalization | 236.27M |
Revenue | |
Operating Income | -63.30M |
Operating Margin | |
Net Income | -60.18M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4574 / 5373 |
Sector : Healthcare | 777 / 1144 |
Industry : Biotechnology | 362 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3520 / 5565 |
Sector : Healthcare | 566 / 1182 |
Industry : Biotechnology | 282 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4456 / 5436 |
Sector : Healthcare | 765 / 1164 |
Industry : Biotechnology | 370 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4895 / 5330 |
Sector : Healthcare | 999 / 1174 |
Industry : Biotechnology | 525 / 667 |